These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 27671545)

  • 1. Alginate therapy is effective treatment for gastroesophageal reflux disease symptoms: a systematic review and meta-analysis.
    Leiman DA; Riff BP; Morgan S; Metz DC; Falk GW; French B; Umscheid CA; Lewis JD
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 27671545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alginate therapy is effective treatment for GERD symptoms: a systematic review and meta-analysis.
    Leiman DA; Riff BP; Morgan S; Metz DC; Falk GW; French B; Umscheid CA; Lewis JD
    Dis Esophagus; 2017 May; 30(5):1-9. PubMed ID: 28375448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastroesophageal reflux in pregnancy: a systematic review on the benefit of raft forming agents.
    Quartarone G
    Minerva Ginecol; 2013 Oct; 65(5):541-9. PubMed ID: 24096290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical Treatment of Gastroesophageal Reflux Disease.
    Kroch DA; Madanick RD
    World J Surg; 2017 Jul; 41(7):1678-1684. PubMed ID: 28321555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances in the Pharmacological Management of Gastroesophageal Reflux Disease.
    Kung YM; Hsu WH; Wu MC; Wang JW; Liu CJ; Su YC; Kuo CH; Kuo FC; Wu DC; Wang YK
    Dig Dis Sci; 2017 Dec; 62(12):3298-3316. PubMed ID: 29110162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological treatment of children with gastro-oesophageal reflux.
    Tighe M; Afzal NA; Bevan A; Hayen A; Munro A; Beattie RM
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD008550. PubMed ID: 25419906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of gastroesophageal reflux disease.
    Pettit M
    Pharm World Sci; 2005 Dec; 27(6):432-5. PubMed ID: 16341949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of reflux disease during pregnancy and lactation.
    Dağlı Ü; Kalkan İH
    Turk J Gastroenterol; 2017 Dec; 28(Suppl 1):S53-S56. PubMed ID: 29199169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of alginate formulations in patients with gastroesophageal reflux disease: a systematic review and meta-analysis of randomized controlled trials.
    Zhao CX; Wang JW; Gong M
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11845-11857. PubMed ID: 33275256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term treatment of gastroesophageal reflux disease.
    van Pinxteren B; Numans ME; Lau J; de Wit NJ; Hungin AP; Bonis PA
    J Gen Intern Med; 2003 Sep; 18(9):755-63. PubMed ID: 12950485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ANTISECRETORY TREATMENT FOR PEDIATRIC GASTROESOPHAGEAL REFLUX DISEASE - A SYSTEMATIC REVIEW.
    Mattos ÂZ; Marchese GM; Fonseca BB; Kupski C; Machado MB
    Arq Gastroenterol; 2017 Dec; 54(4):271-280. PubMed ID: 28954042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised clinical trial: sodium alginate oral suspension is non-inferior to omeprazole in the treatment of patients with non-erosive gastroesophageal disease.
    Chiu CT; Hsu CM; Wang CC; Chang JJ; Sung CM; Lin CJ; Chen LW; Su MY; Chen TH
    Aliment Pharmacol Ther; 2013 Nov; 38(9):1054-64. PubMed ID: 24024757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of adding sodium alginate to omeprazole in patients with nonerosive reflux disease: a randomized clinical trial.
    Manabe N; Haruma K; Ito M; Takahashi N; Takasugi H; Wada Y; Nakata H; Katoh T; Miyamoto M; Tanaka S
    Dis Esophagus; 2012 Jul; 25(5):373-80. PubMed ID: 22050449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.
    Iwakiri K; Kinoshita Y; Habu Y; Oshima T; Manabe N; Fujiwara Y; Nagahara A; Kawamura O; Iwakiri R; Ozawa S; Ashida K; Ohara S; Kashiwagi H; Adachi K; Higuchi K; Miwa H; Fujimoto K; Kusano M; Hoshihara Y; Kawano T; Haruma K; Hongo M; Sugano K; Watanabe M; Shimosegawa T
    J Gastroenterol; 2016 Aug; 51(8):751-67. PubMed ID: 27325300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal Protective Compounds in the Treatment of Gastroesophageal Reflux Disease. A Position Paper Based on Evidence of the Romanian Society of Neurogastroenterology.
    Surdea-Blaga T; Băncilă I; Dobru D; Drug V; Frățilă O; Goldiș A; Grad SM; Mureșan C; Nedelcu L; Porr PJ; Sporea I; Dumitrascu DL
    J Gastrointestin Liver Dis; 2016 Dec; 25(4):537-546. PubMed ID: 27981311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Numans ME; Bonis PA; Lau J
    Cochrane Database Syst Rev; 2001; (4):CD002095. PubMed ID: 11687139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Numans ME; Bonis PA; Lau J
    Cochrane Database Syst Rev; 2000; (2):CD002095. PubMed ID: 10796857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Sigterman KE; Bonis P; Lau J; Numans ME
    Cochrane Database Syst Rev; 2010 Nov; (11):CD002095. PubMed ID: 21069670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacological management of gastroesophageal reflux disease.
    Lowe RC; Wolfe MM
    Minerva Gastroenterol Dietol; 2004 Sep; 50(3):227-37. PubMed ID: 15729198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of add-on therapy with domperidone vs alginic acid in proton pump inhibitor partial response gastro-oesophageal reflux disease in systemic sclerosis: randomized placebo-controlled trial.
    Foocharoen C; Chunlertrith K; Mairiang P; Mahakkanukrauh A; Suwannaroj S; Namvijit S; Wantha O; Nanagara R
    Rheumatology (Oxford); 2017 Feb; 56(2):214-222. PubMed ID: 27179107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.